207 related articles for article (PubMed ID: 25470196)
1. Perspective: incision revision.
Schwartz M
Nature; 2014 Dec; 516(7529):S17. PubMed ID: 25470196
[No Abstract] [Full Text] [Related]
2. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
Kohli A
Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
[No Abstract] [Full Text] [Related]
3. Prevention of hepatocellular carcinoma: the holy grail of hepatitis B treatment.
Sherman M
J Hepatol; 2009 May; 50(5):854-6. PubMed ID: 19303162
[No Abstract] [Full Text] [Related]
4. What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations.
Carrion AF; Martin P
Semin Dial; 2014; 27(5):446-8. PubMed ID: 25204876
[No Abstract] [Full Text] [Related]
5. HEP DART 2005 -- frontiers in drug development for viral hepatitis.
Feitelson MA
IDrugs; 2006 Mar; 9(3):165-7. PubMed ID: 16523376
[No Abstract] [Full Text] [Related]
6. [Hepatology 2009].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1335-9. PubMed ID: 19517326
[No Abstract] [Full Text] [Related]
7. A message to Japan.
Tanikawa K
Oncology; 2002; 62 Suppl 1():101-2. PubMed ID: 11868777
[No Abstract] [Full Text] [Related]
8. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
[No Abstract] [Full Text] [Related]
9. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
Yoshida H; Omata M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
[No Abstract] [Full Text] [Related]
10. A message to Asia.
Suzuki H
Oncology; 2002; 62 Suppl 1():103-4. PubMed ID: 11868778
[No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma.
Desjardins LA
Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in Pakistan.
Abbas Z
J Coll Physicians Surg Pak; 2013 Nov; 23(10):769-70. PubMed ID: 24169381
[No Abstract] [Full Text] [Related]
13. [Treatment of hepatitis B and C -- current standards].
Zeuzem S
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
[No Abstract] [Full Text] [Related]
14. Prevention of hepatocellular carcinoma.
Kew MC
S Afr J Surg; 2011 Apr; 49(2):50-1, 86. PubMed ID: 21614973
[No Abstract] [Full Text] [Related]
15. Haemophilia-related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV-HIV coinfected man with liver failure and hepatocellular carcinoma.
Stemberger M; Seybold U; Eberle J; Denk G; Kolligs F; Kaspar M; Guba M; Pichler M; Spannagl M
Haemophilia; 2015 Mar; 21(2):e131-e133. PubMed ID: 25622556
[No Abstract] [Full Text] [Related]
16. Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.
Aghemo A; Donato MF
Gastroenterology; 2015 Jan; 148(1):13-6. PubMed ID: 25451651
[No Abstract] [Full Text] [Related]
17. [Risk factors and prevention of hepatocellular carcinoma].
Tanaka K
Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
[No Abstract] [Full Text] [Related]
18. [Retinoid].
Moriwaki H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():764-8. PubMed ID: 11762053
[No Abstract] [Full Text] [Related]
19. [Prevention of hepatocellular carcinogenesis by interferon].
Ikeda K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
[No Abstract] [Full Text] [Related]
20. Recent advances in the prevention of hepatocellular carcinoma recurrence.
Lu LC; Cheng AL; Poon RT
Semin Liver Dis; 2014 Nov; 34(4):427-34. PubMed ID: 25369304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
